124 related articles for article (PubMed ID: 32521616)
1. Switching to Integrase Inhibitors Unlinked to Weight Increase in Perinatally HIV-Infected Young Adults and Adolescents: A 10-Year Observational Study.
Taramasso L; Di Biagio A; Bovis F; Forlanini F; Albani E; Papaioannu R; Giacomet V
Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32521616
[TBL] [Abstract][Full Text] [Related]
2. The effect of a treatment switch to integrase Strand transfer inhibitor-based regimens on weight gain and other metabolic syndrome-related conditions.
Maman O; Ahmad WA; Perzon O; Mahlab-Guri K; Elbirt D; Elinav H
BMC Infect Dis; 2024 Feb; 24(1):221. PubMed ID: 38373940
[TBL] [Abstract][Full Text] [Related]
3. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; Reiss P;
PLoS One; 2021; 16(5):e0251205. PubMed ID: 33951089
[TBL] [Abstract][Full Text] [Related]
4. Contribution of integrase inhibitor use, body mass index, physical activity and caloric intake to weight gain in people living with HIV.
Guaraldi G; Milic J; Bacchi E; Carli F; Menozzi M; Franconi I; Raimondi A; Ciusa G; Masi V; Belli M; Guaraldi S; Aprile E; Mancini M; Mussini C; Lake JE; Erlandson KM
HIV Res Clin Pract; 2022 Nov; 24(1):1-6. PubMed ID: 36883678
[No Abstract] [Full Text] [Related]
5. One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor.
Verburgh ML; Wit FWNM; Boyd A; Verboeket SO; Reiss P; van der Valk M
Open Forum Infect Dis; 2022 Jul; 9(7):ofac291. PubMed ID: 35873291
[TBL] [Abstract][Full Text] [Related]
6. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens.
Milic J; Renzetti S; Ferrari D; Barbieri S; Menozzi M; Carli F; Dolci G; Ciusa G; Mussini C; Calza S; Guaraldi G
AIDS; 2022 Oct; 36(12):1643-1653. PubMed ID: 35727163
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Integrase Inhibitor-based Antiretroviral Therapy in a Clinical Cohort of Treatment-experienced Children, Adolescents and Young Adults With HIV Infection.
Levy ME; Griffith C; Ellenberger N; Monroe AK; Castel AD; Rakhmanina N;
Pediatr Infect Dis J; 2020 May; 39(5):421-428. PubMed ID: 32176183
[TBL] [Abstract][Full Text] [Related]
8. Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors.
Chen YW; Hardy H; Pericone CD; Chow W
J Health Econ Outcomes Res; 2020; 7(2):102-110. PubMed ID: 32766375
[TBL] [Abstract][Full Text] [Related]
9. Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.
Gianotti N; Poli A; Nozza S; Galli L; Galizzi N; Ripa M; Merli M; Carbone A; Spagnuolo V; Lazzarin A; Castagna A
BMC Infect Dis; 2017 Nov; 17(1):723. PubMed ID: 29145807
[TBL] [Abstract][Full Text] [Related]
10. Weight Gain Associated With Integrase Stand Transfer Inhibitor Use in Women.
Kerchberger AM; Sheth AN; Angert CD; Mehta CC; Summers NA; Ofotokun I; Gustafson D; Weiser SD; Sharma A; Adimora AA; French AL; Augenbraun M; Cocohoba J; Kassaye S; Bolivar H; Govindarajulu U; Konkle-Parker D; Golub ET; Lahiri CD
Clin Infect Dis; 2020 Jul; 71(3):593-600. PubMed ID: 31504324
[TBL] [Abstract][Full Text] [Related]
11. Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV.
Han WM; Kerr SJ; Avihingsanon A; Boettiger DC
J Antimicrob Chemother; 2022 Nov; 77(12):3242-3247. PubMed ID: 36101517
[TBL] [Abstract][Full Text] [Related]
12. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus.
Chow W; Donga P; Côté-Sergent A; Rossi C; Lefebvre P; Lafeuille MH; Emond B; Hardy H
Curr Med Res Opin; 2020 Aug; 36(8):1313-1323. PubMed ID: 32459155
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy.
Erlandson KM; Wu K; Lake JE; Samuels DC; Bares SH; Tassiopoulos K; Koethe JR; Brown TT; Leonard M; Benson CA; Haas DW; Hulgan T;
AIDS; 2021 Mar; 35(3):439-445. PubMed ID: 33252493
[TBL] [Abstract][Full Text] [Related]
14. Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors.
Chen YW; Anderson D; Pericone CD; Donga P
J Health Econ Outcomes Res; 2022; 9(1):1-10. PubMed ID: 35083364
[No Abstract] [Full Text] [Related]
15. Energy balance and body composition after switch between integrase strand transfer inhibitors and doravirine among people with HIV.
Erlandson KM; Mohaweche R; Morrow M; Mawhinney S; Khuu V; Boyd M; Balasubramanyam A; Melanson EL; Lake JE
J Antimicrob Chemother; 2024 Jan; 79(1):179-185. PubMed ID: 38000089
[TBL] [Abstract][Full Text] [Related]
16. Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV: a longitudinal cohort study.
Hwang YJ; Lesko CR; Brown TT; Alexander GC; Zalla LC; Keruly JC; Snow LN; Pytell JD; Falade-Nwulia O; Jones JL; Moore RD; Fojo AT
AIDS; 2024 Jun; ():. PubMed ID: 38864578
[TBL] [Abstract][Full Text] [Related]
17. Weight Changes With Integrase Strand Transfer Inhibitor Therapy in the Management of HIV Infection: A Systematic Review.
Hester EK; Greenlee S; Durham SH
Ann Pharmacother; 2022 Feb; ():10600280211073321. PubMed ID: 35130714
[TBL] [Abstract][Full Text] [Related]
18. Real-world weight changes in people with HIV-1 at risk of weight gain (female, Black or Hispanic) switching from integrase strand transfer inhibitors.
Donga P; Emond B; Shah A; Bookhart BK; Anderson D; Vermette-Laforme M; Rossi C; Lafeuille MH
J Comp Eff Res; 2023 Jan; 12(1):e220147. PubMed ID: 36445208
[No Abstract] [Full Text] [Related]
19. Weight Gain in Incarcerated Individuals Living With HIV After Switching to Integrase Strand Inhibitor-Based Therapy.
Goldberg RN; Kania AT; Michienzi SM; Patel M; Badowski ME
J Int Assoc Provid AIDS Care; 2021; 20():2325958221996860. PubMed ID: 33626965
[TBL] [Abstract][Full Text] [Related]
20. Changes in central adipose tissue after switching to integrase inhibitors.
Debroy P; Feng H; Miao H; Milic J; Ligabue G; Draisci S; Besutti G; Carli F; Menozzi M; Mussini C; Guaraldi G; Lake JE
HIV Res Clin Pract; 2020 Dec; 21(6):168-173. PubMed ID: 33459579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
